SAUDI ARABIA AND MIDDLE EAST RADIOISOTOPE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Saudi Arabia and Middle East Radioisotope Market, By Radioisotopes (Molebdennum 99/Technetium-99, Iodine-131, Iodine-125, Yttrium-90, Strontium-89, Cesium-137, Cobalt-60, Iridium-192, Selenium-75, Lutetium 177, Germanium-68/gallium-68, Nickel-63, Copper-67, Scandium 47, Phosphorus-32, Holmium 166, Chromium 51, Samarium 153, Rhenium-188, Terbium-161, Radium -226, Rhenium-186, Actinium-225, and Others), By Application (Medical Application (Medical Imaging, Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET)), Radiation Therapy (Gamma radiotherapy, Brachytherapy, Targeted-Alpha-Therapy (TAT)), Clinical Research (Cell Biology, Drug Development, Metabolic Pathway Study) and Industrial Application (Inspection/Monitoring, Measuring, Quality Control and Testing, Sterilization, Food Preservation), By End User (Hospitals, Imaging Centers, Research Centers, Biopharmaceutical Companies, Food Industry, Chemical Industry, and Others)

Published In : Feb 2024
Code : CMI6672
Pages :250
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Saudi Arabia and Middle East Radioisotope Market Country Insights:

Saudi Arabia Saudi Arabia has emerged as the dominant leader in the Saudi Arabia and Middle East radioisotope market. The country accounts for over half of the total market share in the region due to strong government support for the development of the healthcare sector. Saudi Arabia has seen huge investments from both public and private players to boost manufacturing infrastructure and facilitate easy access to advanced medical facilities. This has contributed to growth in the demand for medical radioisotopes for diagnostic imaging and treatment procedures. The country also has a large pool of skilled healthcare professionals and low-cost facilities compared to other nations, attracting medical tourism from neighboring markets. Another major factor for Saudi Arabia's dominance is its strategic geographical location. It shares borders with many Middle Eastern countries and also has good trade relations with African and Asian nations. This provides local isotope manufacturers an advantage in catering to the needs of nearby international markets in a time-efficient manner. Export of isotopes has emerged as a key source of revenue for companies based in Saudi Arabia. Free trade agreements with different countries have further opened up opportunities for exporters.
U.A.E is emerging as the fastest growing regional market for radioisotopes. Significant economic growth and healthcare sector reforms have boosted demand. U.A.E has a high per capita GDP and spends extensively on the latest medical technologies and facilities. This modern infrastructure equipped with state-of-the-art diagnostic and treatment centers requires a continuous supply of specialized isotopes. Local production still remains relatively low to meet the domestic needs. However, the U.A.E government is introducing initiatives to encourage investments in this sector to reduce import dependence over the long run.

By Country: U.A.E, Israel, Saudi Arabia, Kuwait, Qatar, Oman, Bahrain, Yemen, Iran, Iraq, Jordan, Syria, Lebanon, Egypt, Libya, Morocco, Mauritania, Tunisia, Sudan, Algeria, Cyprus, and Turkey